Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

Recruiting

Glecaprevir/PibrentasvirStudy of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

Sponsor:

AbbVie

Code:

NCT07419347

Conditions

Hepatitis C Virus (HCV)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-31. This information was provided to ClinicalTrials.gov by AbbVie on 2026-03-30.